← Leaderboards
Mitchell W Mutz
Amplyx Pharmaceuticals, Inc.
$6,956,651
Attributed
$6,956,651
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2011–15$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,956,651 · 11
By mechanism
R43$3,957,404 · 8
R44$2,999,247 · 3
Top collaborators
No co-investigators on record.
Most similar at Amplyx Pharmaceuticals, Inc.
Same institution · by research overlap
- Karen Joy Shaw$4,769,794
Others in their field
Top investigators on “Libraries”
- David Heimbrook · Leidos Biomedical Research, Inc.$860,725,506
- Leonard Freedman · Leidos Biomedical Research, Inc.$792,858,643
- Richard A Gibbs · Baylor College Of Medicine$428,954,539
- Lynn Briscoe · Leidos Biomedical Research, Inc.$225,263,761
- Leonard Freedmand · Leidos Biomedical Research, Inc.$160,413,316
- Robert H Waterston · Washington University$155,287,704
Research focus
LibrariesToxic EffectMortality Vital StatisticsSalesDesignInfectionAntifungal AgentsInhibitor/AntagonistIn VitroRelative (Related Person)AnalogFungusFk506ChemistryBaseFluconazoleTreatment OutcomeTriazolesTheoriesAcuteAdverse EffectsCalcineurin InhibitorIncidenceBiological Adaptation To Stress
Grant awards (17)
A Combination Therapy Approach to Treating Drug Resistant Fungal Infections$750,723
R44 · FY2015 · AI · contact PI
Developing a New Therapeutic for the Treatment of Invasive Aspergillosis$749,985
R44 · FY2015 · AI · contact PI
A Computer Modeling Approach$749,999
R44 · FY2014 · NS · contact PI
A Combination Therapy Approach to Treating Drug Resistant Fungal Infections$748,540
R44 · FY2014 · AI · contact PI
Discovering a Combination Therapeutic Approach to Use in the Treatment of Cryptoc$347,172
R43 · FY2014 · NS · contact PI
Developing a New Therapeutic for the Treatment of Invasive Aspergillosis$299,119
R43 · FY2014 · AI · contact PI
Discovering a Targeted Inositol Phosphorylceramide Synthase Inhibitor to Improve$225,000
R43 · FY2014 · AI · contact PI
Discovering a Combination Therapeutic Approach to Use in the Treatment of Cryptoc$349,547
R43 · FY2013 · NS · contact PI
A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of$347,057
R43 · FY2013 · NS · contact PI
A Structural Approach for Treating Drug Resistant Fungal Pathogens$300,000
R43 · FY2013 · AI · contact PI
Developing a New Therapeutic for the Treatment of Invasive Aspergillosis$299,985
R43 · FY2013 · AI · contact PI
Designing HIV Protease Inhibitors with Lower Dosing Requirements and Lower Toxici$284,518
R43 · FY2013 · AI · contact PI
A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of$349,999
R43 · FY2012 · NS · contact PI
Discovering a Novel Immunophilin to Lower the Toxicity of Cancer Therapeutics$300,959
R43 · FY2012 · TR · contact PI
Designing HIV Protease Inhibitors with Lower Dosing Requirements and Lower Toxici$295,904
R43 · FY2012 · AI · contact PI
A Structural Approach for Treating Drug Resistant Fungal Pathogens$258,144
R43 · FY2012 · AI · contact PI
A Combination Therapy Approach to Treating Drug Resistant Fungal Infections$300,000
R43 · FY2011 · AI · contact PI